Cytokinetics (CYTK) Return on Equity [ROE] (2011 - 2024)
Cytokinetics (CYTK) reported Return on Equity [ROE] of -1184.61% for Q3 2024.
Powered by 
Analysis
Cytokinetics (CYTK) Return on Equity [ROE] (2011 - 2024) Analysis & Trends
For FY2022, Cytokinetics posted Return on Equity [ROE] of -505.46%, down 391.95 percentage points from FY2021.
- Return on Equity [ROE] has a five-year change of -391.44 percentage points (FY2017 to FY2022).
- By year, Return on Equity [ROE] came in at -113.51% in FY2021 (+101.05 pp), -214.56% in FY2020 (+1192.25 pp), -1406.81% in FY2019 (-1270.25 pp) and -136.57% in FY2018 (-22.55 pp).
- The Q3 2024 figure ranks as the highest quarterly Return on Equity [ROE] in data going back to Q3 2011.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROE (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 25.32% |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | - |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 7.21% |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | 84.40% |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | 21.39% |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 83.75% |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | -18.38% |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 4.97% |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 22.24% |
| 10 | Cytokinetics | 9.16 Bn | 5.33 Bn | 25.89 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2024 | -1,184.61% |
| Sep 30, 2022 | -493.42% |
| Jun 30, 2022 | -170.04% |
| Mar 31, 2022 | -132.60% |
| Dec 31, 2021 | -82.27% |
| Sep 30, 2021 | -163.65% |
| Jun 30, 2021 | -338.38% |
| Mar 31, 2021 | -132.50% |
| Dec 31, 2020 | -83.58% |
| Sep 30, 2020 | -268.21% |
| Mar 31, 2019 | -623.81% |
| Dec 31, 2018 | -237.72% |
| Sep 30, 2018 | -168.63% |
| Jun 30, 2018 | -138.31% |
| Mar 31, 2018 | -117.00% |
| Dec 31, 2017 | -94.52% |
| Sep 30, 2017 | -47.85% |
| Jun 30, 2017 | -8.38% |
| Mar 31, 2017 | 3.21% |
| Dec 31, 2016 | 18.37% |
API Access
Cytokinetics Return on Equity [ROE] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=CYTK&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-equity-[roe]", "ticker": "CYTK", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=CYTK&period=max&api_key=YOUR_API_KEY");
const data = await res.json();